SamuelNLedermanMD

Obstetrics & Gynecology • Lake Worth, FL

Regional Medical Director, Womens Care Florida

Join to view full profile

Dr. Lederman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lederman's full profile

Already have an account?

Office
4671 S Congress Ave
Suite 100 B
Lake Worth, FL 33461
Phone+1 561-434-0111

Fax+1 561-434-4868

Summary

Dr. Samuel Lederman is an obstetrician/gynecologist in Lake Worth, FL and is affiliated with multiple hospitals in the area, including Good Samaritan Medical Center, JFK Medical Center, St. Mary's Medical Center, and JFK Medical Center North Campus. He received his medical degree from University of Miami Miller School of Medicine and has been in practice 30 years. He also speaks multiple languages, including Spanish and French. He is experienced in general obstetrics and gynecology, laparoscopy, general gynecology, clinical research, and electronic health records.

Education & Training

University of ColoradoResidency, Obstetrics and Gynecology, 1987 - 1991
University of Miami Leonard M. Miller School of MedicineClass of 1987

Certifications & Licensure

FL State Medical License 1991 - 2025
CO State Medical License 1989 - 2009
American Board of Obstetrics and Gynecology Obstetrics & Gynecology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2011, 2013-2014
Davies award HIMSS, 2008
Fellow (FACOG) American Congress of Obstetricians and Gynecologists

Clinical Trials

Eight-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Associated With Menopause Start of enrollment: 2008 Nov 01
Completed
Phase 2
24-Week Efficacy & Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms Start of enrollment: 2010 Mar 01
Completed
Phase 3
Web Based Orthopaedic Sports Medicine Registry Start of enrollment: 2010 Sep 01
Recruiting
Safety and Efficacy of NAB001 in the Treatment of Mild to Moderate Onychomycosis of the Toenails Start of enrollment: 2010 Sep 01
Terminated
Phase 3
Safety and Efficacy of Oral Encochleated Amphotericin B (CAMB/MAT2203) in the Treatment of Vulvovaginal Candidiasis (VVC) Start of enrollment: 2016 Nov 01
Completed
Phase 2
Comparative Study to Evaluate Efficacy and Safety of Gepotidacin to Nitrofurantoin in Treatment of Uncomplicated Urinary Tract Infection (UTI) Start of enrollment: 2020 Apr 23
Completed
Phase 3
Efficacy and Safety of MM-II for Treatment of Knee Pain in Subjects With Symptomatic Knee Osteoarthritis Start of enrollment: 2020 Dec 22
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

2 citations
A real-world comparison of the clinical and economic utility of OVA1 and CA125 in assessing ovarian tumor malignancy risk.
Gerard P Reilly, David A Gregory, Dennis J Scotti, Samuel Lederman, Wade A Neiman
Journal of Comparative Effectiveness Research. 2023-06-01
66 citations
Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study.
Samuel Lederman, Faith D Ottery, Antonio Cano, Nanette Santoro, Marla Shapiro
Lancet. 2023-04-01
43 citations
Ibrexafungerp versus placebo for vulvovaginal candidiasis treatment: a phase 3, randomized, controlled superiority trial (VANISH 303)
Jane R. Schwebke, Ryan Sobel, Janet K Gersten, Steven A Sussman, Samuel N. Lederman
Clinical Infectious Diseases. 2021-09-01

Professional Memberships

American College of Obstetricians and Gynecologists
Fellow

Other Languages

Spanish, French

External Links

Practicehttp://www.womenscarefl.com
Researchhttp://www.altusresearch.com
Aestheticshttp://www.laserskinsolutions.com